BREAKING NEWS: Salt Lake City-based Recursion Pharmaceuticals Announces a $200 Million Public Offering
Salt Lake City, Utah-based Recursion Pharmaceuticals (NASDAQ:RXRX) announced last Wednesday, 26 June 2024, that it plans to raise $200 million in a secondary public offering.
According to its news release, Recursion "... intends to offer and sell $200 million of shares of its Class A common stock in an